DNA 與 RNA 合成研究回顧：2024 年

全球 DNA定序市場規模預計將從 2024 年的148 億美元增至 2029 年底的 348 億美元，預測期間的複合年成長率為 18.6%。

全球臨床應用次世代定序市場規模預計將從 2023 年的 219 億美元成長到 2028 年的 529 億美元，預測期內的複合年成長率為 19.3%。

全球 RNA定序市場規模預計將從 2024 年的 年終的 103 億美元，預測期間的複合年成長率為 19.1%。

DNA 和 RNA 合成是去氧核糖核酸（DNA）和核糖核酸（RNA）的人工生產。建構 DNA 和 RNA 的合成技術的發展提高了我們理解和設計生物學的能力。我們提供各種類型的合成 DNA，包括寡核苷酸、基因、DNA 和 RNA 片段，並可根據客戶需求進行客製化。合成 DNA 和 RNA 被用於開發新藥和疫苗、遺傳疾病的基因療法以及用於檢測病原體和疾病的分子診斷工具（如 PCR 檢測和基於核酸的感測器）。

DNA 和 RNA 合成技術在合成生物學、分子遺傳學和生物工程等科學領域至關重要，可為各種研究、診斷和治療應用產生客自訂的DNA 和 RNA 序列。基因組學研究的快速擴展、治療性 DNA 和 RNA 應用的進步以及對個人化醫療的日益成長的需求，正在推動 DNA 和 RNA 合成市場的顯著成長。 CRISPR、基因治療和合成生物學的創新正在推動對 DNA 和 RNA 合成的需求激增，使其成為開發標靶治療和創新基因研究解決方案的重要工具。

本研究評論包括 BCC Research 於 2024 年發布的有關基因編輯療法、DNA定序、次世代定序、RNA定序RNAi 技術病毒載體和質體DNA 的報告的亮點和摘錄，並包括每個市場概況的摘要、市場影響因素和市場機會的分析、法律制度、新興技術和技術發展趨勢、市場規模趨勢和預測，以及各個細分市場和細分市場的細分市場趨勢、市場規模趨勢和預測，以及各個細分市場和細分市場的細分市場。

目錄

第 1 章 簡介

2. 基因編輯治療市場（BIO259A）

• 研究範圍
• 市場展望
• 市場摘要
• 基因編輯治療市場概覽
• 基因組編輯工具的類型
• Meganucleases
• 鋅指核酸酶
• 轉錄活化因子樣效應核酸酶
• CRISPR/CRISPR 相關蛋白
• 基因編輯療法
• 市場動態
• 市場推進因素
• 市場挑戰
• 基因編輯治療的新技術與機會
• 基礎編輯
• PrimeEdit
• Cas-Clover 和 Cas-FOKl
• CRISPR 干擾和 CRISPR 激活
• RNA編輯
• 人工智慧在基因組編輯的應用
• 基因編輯治療市場分析
• 概述
• Casgevy
• 基因編輯治療市場按地區分類
• 北美洲
• 歐洲
• 新興市場
• 基因編輯治療市場的 ESG 表現
• 基因編輯公司的 ESG 實踐
• BCC的結語

3.全球DNA定序：研究、應用與臨床市場（BIO045J）

• 研究範圍
• 市場展望
• 市場摘要
• 市場概況
• DNA 的重要性
• 遺傳變異與分析
• NGS
• TGS（長讀定序）
• 研究與應用
• 研發應用
• 應用領域
• D2C
• 生物製藥
• 農業
• 法醫學
• 微生物組
• 合成生物學
• 市場動態
• 市場推進因素
• 市場限制
• 新興技術
• 長讀定序技術
• SMRT定序
• 奈米孔定序
• 空間基因組學和轉錄組學
• 單細胞 DNA定序
• 超低輸入定序
• CRISPR-Cas9、基因組編輯和定序技術的整合
• DNA定序中的人工智慧和機器學習
• 市場區隔：按技術
• 概述
• NGS
• TGS
• 桑格定序
• 焦磷酸測序
• 市場區隔：按地區
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• DNA定序序產業的 ESG 表現
• 環境績效
• 社會績效
• 管治績效
• DNA定序產業的ESG風險評估
• BCC的結語

第 4 章次世代定序：新興臨床應用與全球市場（BIO126E）

• 研究範圍
• 市場展望
• 市場摘要
• 市場概況
• 液體和組織切片檢查
• 臨床NGS的成長要素
• 主要趨勢
• 市場動態
• 市場推進因素
• 市場限制
• 次世代定序新技術
• 研究與開發計劃和項目
• 1+ Million Genomes
• Access to Treatment and Testing (ACTT)
• Access to Comprehensive Genomic Profiling Coalition (ACGP)
• Africa Pathogen Genomics Initiative
• Blood Profiling Atlas
• Cancer-ID
• Cancer Moon Shots Program
• China Precision Medicine Initiative
• ClinGen
• CTC Trap Consortium
• diaRNAgnosis Project
• Early Cancer Detection Consortium
• EpiFemCare
• France Genomic Medicine Plan
• Friends of Cancer Research Project
• Genomic Medicine Sweden
• HCA-Organoid
• Human Cell Atlas
• Human Immunomics Initiative
• Immunomonitor Consortium
• Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy Program
• Intervene
• Liquid Biopsies and Imaging for Improved Cancer Care
• Liquid Biopsy-Based Malignant Tumor Early Screening Technology Research and Development Project
• Liver Cancer Early Screening Comprehensive Prevention and Control Project
• Lung Cancer Genomic Screening Project for Individualized Medicine in Asia
• Million Veteran Program
• Medical Genome Initiative
• MedSeq
• 市場區隔：依疾病類別
• 概述
• 市場區隔：按地區
• 北美洲
• 歐洲
• 亞太地區
• 次世代定序產業的 ESG 表現
• 案例研究
• BCC 的看法

5. RNA定序：技術與全球市場（BIO147B）

• 研究範圍
• 市場展望
• 市場摘要
• 市場概況
• 技術背景
• 轉錄組學技術
• 轉錄組學的 RNA定序
• RNA-Seq 實驗工作流程
• RNA定序的監管現狀
• 成長戰略提案
• 市場動態
• 市場促進因素
• 市場限制
• 市場機會
• RNA定序市場的新興技術和發展
• 單細胞 RNA定序
• 其他新興單細胞技術
• 市場區隔：RNA定序產品
• 裝置
• 工具和試劑
• 軟體和服務
• 市場區隔：按地區
• 概述
• 北美洲
• 歐洲
• 亞太地區
• 其他地區
• RNA定序市場的永續性：ESG 視角
• RNA定序產業的 ESG 實踐
• 環境績效
• 社會績效
• 管治績效
• BCC的結語

6. RNAi技術與全球市場（BIO127C）

• 研究範圍
• 市場展望
• 市場摘要
• 市場概況
• RNA干擾概述
• RNA干擾：作用機制
• 啟動階段
• 效應階段
• 小干擾RNA（siRNA）
• 微型RNA （miRNA）
• 小髮夾 RNA（shRNA）
• 市場動態
• 市場促進因素
• 市場問題
• RNAi 技術的新興技術與機會
• 治療
• 診斷
• 用於非侵入性健康監測的循環 miRNA 診斷
• 農業
• 按技術分類的市場
• 治療
• 診斷
• 試劑和工具
• 農業
• 區域市場
• 概述
• 北美洲
• 歐洲
• 新興市場
• RNAi 技術產業的永續性：ESG 視角
• 環境計劃
• 社會貢獻活動
• 管治舉措
• 案例研究
• BCC的結語

7. 病毒載體和質體DNA：技術與全球市場（BIO192B）

• 研究範圍
• 市場展望
• 市場摘要
• 市場概況
• 細胞和基因治療
• 市場動態
• 市場推進因素
• 市場挑戰
• 新科技和機會
• 病毒載體生產中的人工智慧
• 狗骨DNA
• FRAGment Recycler：質體DNA 合成新技術
• 病毒載體和質體DNA 技術市場（按產品類型）
• 病毒載體和質體DNA 技術市場（按應用）
• 病毒載體和質體DNA 技術市場（按地區）
• 概述
• 北美洲
• 歐洲
• 亞太地區
• 拉丁美洲
• 其他地區
• 病毒載體和質體DNA 技術市場的永續性：ESG 視角
• 環境因素
• 社會因素
• 管治因素
• 主要公司ESG表現
• 主要企業ESG表現
• 龍沙：ESG 績效
• 賽默飛世爾：ESG 績效
• 結論

第 8 章 附錄

The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.

The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a CAGR of 19.3% from 2023 through 2028.

The global market for RNA sequencing is expected to grow from $4.3 billion in 2024 and is projected to reach $10.3 billion by the end of 2029, at a CAGR of 19.1% during the forecast period of 2024 to 2029.

Research Review Scope

DNA and RNA synthesis artificially manufactures deoxyribose nucleic acid (DNA) and ribonucleic acid (RNA). Developing synthetic techniques to construct DNA and RNA has improved the ability to understand and engineer biology. Different types of synthesized DNA, such as oligonucleotides, genes, and DNA and RNA fragments, are available and can be utilized per the customer's needs. Synthetic DNA and RNA are used to develop new drugs and vaccines, gene therapies for genetic disorders, and the development of molecular diagnostic tools, including polymerase chain reaction (PCR) assays and nucleic-acid-based sensors, to detect pathogens and diseases.

DNA and RNA synthesis technology is vital in scientific fields such as synthetic biology, molecular genetics, and bioengineering, creating custom DNA and RNA sequences for various research, diagnostic, and therapeutic applications. The rapid expansion of genomics research, advancements in therapeutic DNA and RNA applications, and the growing need for personalized medicine are driving exceptional growth in the DNA & RNA synthesis market. The innovations in CRISPR, gene therapy, and synthetic biology show that the demand for DNA and RNA synthesis has risen sharply, positioning it as a pivotal tool in developing targeted treatments and innovative genetic research solutions.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2024 Research Review of DNA and RNA synthesis technology provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2024:

• BIO259A Gene Editing Therapeutics Market
• BIO045J Global DNA Sequencing: Research Applied and Clinical Markets
• BIO126E Next-generation Sequencing: Emerging Clinical Applications and Global Markets
• BIO147B RNA Sequencing: Technologies and Global Markets
• BIO127C RNAi Technologies and Global Markets
• BIO192B Viral Vector and Plasmid DNA: Technologies and Global Markets

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Gene Editing Therapeutics Market (BIO259A)

• Scope of Report of Gene Editing Therapeutics
• Market Outlook of Gene Editing Therapeutics
• Market Summary
• Market Overview of Gene Editing Therapeutics
• Genome-Editing Tool Types
• Meganucleases
• Zinc Finger Nucleases
• Transcription Activator-like Effector Nucleases
• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-Associated Protein 9
• Gene editing Therapeutics
• Market Dynamics of Gene Editing Therapeutics
• Market Driver
• Market Challenges
• Emerging Technologies and Opportunities of Gene Editing Therapeutics
• Base Editing
• Prime Editing
• Cas-Clover and Cas-FOKl
• CRISPR Interference and CRISPR Activation
• RNA Editing
• Artificial Intelligence in Genome Editing
• Market Analysis of Gene Editing Therapeutics
• Overview
• Casgevy
• Market of Gene Editing Therapeutics by Region
• North America
• Europe
• Emerging Markets
• ESG Performance in Gene Editing Therapeutics Market
• ESG Practices in the Gene Editing Companies
• Concluding Remarks from BCC Research

Chapter 3 Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)

• Scope of Report of DNA Sequencing: Research, Applied and Clinical Markets
• Market Outlook of DNA Sequencing: Research, Applied and Clinical Markets
• Market Summary of DNA Sequencing: Research, Applied and Clinical Markets
• Market Overview of DNA Sequencing: Research, Applied and Clinical Markets
• Importance of DNA
• Genetic Variation and Analysis
• NGS (Second-generation Sequencing)
• TGS (Long-read Sequencing)
• Research and Applied Applications
• R&D Applications
• Applied Applications
• Direct to Consumer
• Biopharma
• Agriculture
• Forensics
• Microbiome
• Synthetic Biology
• Market Dynamics of DNA Sequencing: Research, Applied and Clinical Markets
• Market Driver
• Market Restraint
• Emerging Technologies of DNA Sequencing: Research, Applied and Clinical Markets
• Long-read Sequencing Technologies
• SMRT Sequencing
• Nanopore Sequencing
• Spatial Genomics and Transcriptomics
• Single-cell DNA Sequencing
• Ultra-low Input Sequencing
• CRISPR-Cas9 and Genome-editing Integration with Sequencing Technologies
• AI and Machine Learning in DNA Sequencing
• Market Breakdown of DNA Sequencing: Research, Applied and Clinical Markets by Technology
• Overview
• NGS
• TGS
• Sanger Sequencing
• Pyrosequencing
• Market Breakdown of DNA Sequencing: Research, Applied and Clinical Markets by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• ESG Performance in DNA Sequencing Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings in the DNA Sequencing Industry
• Concluding Remarks from BCC Research

Chapter 4 Next-generation Sequencing: Emerging Clinical Applications and Global Markets (BIO126E)

• Scope of Report of Next-generation Sequencing
• Market Outlook of Next-generation Sequencing
• Market Summary of Next-generation Sequencing
• Market Overview of Next-generation Sequencing
• Liquid and Tissue Biopsy
• Growth Drivers of Clinical NGS
• Key Trends
• Market Dynamics of Next-generation Sequencing
• Market Driver
• Market Restraint
• Emerging Technologies of Next-generation Sequencing
• R&D Initiatives and Programs
• 1+ Million Genomes
• Access to Treatment and Testing (ACTT)
• Access to Comprehensive Genomic Profiling Coalition (ACGP)
• Africa Pathogen Genomics Initiative
• Blood Profiling Atlas
• Cancer-ID
• Cancer Moon Shots Program
• China Precision Medicine Initiative
• ClinGen
• CTC Trap Consortium
• diaRNAgnosis Project
• Early Cancer Detection Consortium
• EpiFemCare
• France Genomic Medicine Plan
• Friends of Cancer Research Project
• Genomic Medicine Sweden
• HCA-Organoid
• Human Cell Atlas
• Human Immunomics Initiative
• Immunomonitor Consortium
• Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy Program
• Intervene
• Liquid Biopsies and Imaging for Improved Cancer Care
• Liquid Biopsy-Based Malignant Tumor Early Screening Technology Research and Development Project
• Liver Cancer Early Screening Comprehensive Prevention and Control Project
• Lung Cancer Genomic Screening Project for Individualized Medicine in Asia
• Million Veteran Program
• Medical Genome Initiative
• MedSeq
• Market Breakdown of Next-generation Sequencing by Disease Category
• Overview
• Market Breakdown of Next-generation Sequencing by Region
• North America
• Europe
• Asia-Pacific
• ESG Performance in Next-generation Sequencing Industry
• Case Study
• BCC Research Viewpoint

Chapter 5 RNA Sequencing: Technologies and Global Markets (BIO147B)

• Scope of Report of RNA Sequencing
• Market Outlook of RNA Sequencing
• Market Summary of RNA Sequencing
• Market Overview of RNA Sequencing
• Technology Background
• Transcriptomics Technologies
• RNA Sequencing for Transcriptomics
• RNA-Seq Experimental Workflow
• Regulatory Landscape of RNA Sequencing
• Growth Strategy Recommendations
• Market Dynamics of RNA Sequencing
• Market Drivers
• Market Restraints
• Market Opportunity
• Emerging Technologies and Developments of RNA Sequencing Market
• Single-Cell RNA Sequencing
• Other Emerging Single-Cell Technologies
• Market Breakdown of RNA Sequencing by Product
• Instruments
• Tools and Reagents
• Software and Services
• Market Breakdown of RNA Sequencing by Region
• Overview
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in RNA Sequencing Market: ESG Perspective
• ESG Practices in the RNA Sequencing Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC Research

Chapter 6 RNAi Technologies and Global Markets ( BIO127C)

• Scope of Report of RNAi Technologies
• Market Snapshot of RNAi Technologies
• Market Summary of RNAi Technologies
• Market Overview of RNAi Technologies
• RNA Interference Overview
• RNA Interference: Mechanism of Action
• Initiation Phase
• Effector Phase
• Small Interfering RNAs (siRNAs)
• MicroRNAs (miRNAs)
• Small Hairpin RNAs (shRNAs)
• Market Dynamics of RNAi Technologies
• Market Drivers
• Market Challenges
• Emerging Technologies and Opportunities of RNAi Technologies
• Therapeutics
• Diagnostics
• Circulating miRNA Diagnostics for Non-invasive Health Monitoring
• Agriculture
• Market for RNAi Technology by Technology
• Therapeutics
• Diagnostics
• Reagents and Tools
• Agriculture
• Market for RNAi Technology by Region
• Overview
• North America
• Europe
• Emerging Markets
• Sustainability in RNAi Technology Industry: An ESG Perspective
• Environmental Initiatives
• Social Initiatives
• Governance Initiatives
• Case Study
• Concluding Remarks from BCC

Chapter 7 Viral Vector and Plasmid DNA: Technologies and Global Markets (BIO192B)

• Scope of Report of Viral Vector and Plasmid DNA
• Market Outlook of Viral Vector and Plasmid DNA
• Market Summary of Viral Vector and Plasmid DNA
• Market Overview of Viral Vector and Plasmid DNA
• Cell and Gene Therapy
• Market Dynamics of Viral Vector and Plasmid DNA
• Market Driver
• Market Challenges
• Emerging Technologies and Opportunities of Viral Vector and Plasmid DNA
• AI in Viral Vector Production
• Doggybone DNA
• FRAGment Recycler: A New Technology for Plasmid DNA Synthesis
• Market for Viral Vector and Plasmid DNA Technologies by Product Type
• Market for Viral Vector and Plasmid DNA Technologies by Application
• Market for Viral Vector and Plasmid DNA Technologies by Region
• Overview
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest of the World
• Sustainability in the Market for Viral Vector and Plasmid DNA Technologies: An ESG Perspective
• Environmental Factors
• Social Factors
• Governance Factors
• ESG Performance Among Major Companies
• ESG Performance of Select Companies
• Lonza: ESG Performance
• Thermo Fisher: ESG Performance
• Conclusion

Chapter 8 Appendix

• Methodology
• Analyst's Credentials

List of Tables

• Table 1 : Global Market for Gene Editing Therapeutics, Through 2029
• Table 2 : Comparison of Genome-Editing Tools
• Table 3 : U.S. Adults Age 50 Years and Older with Multiple Chronic Conditions, 2020-2050
• Table 4 : Global Cases and Deaths Due to Various Cancers, 2022
• Table 5 : Comparison of Cas9-derived Proteins with Regular SpCas9
• Table 6 : Global Market for Gene Editing Therapeutics, Through 2029
• Table 7 : Global Market for Gene Editing Therapeutics, by Region, Through 2029
• Table 8 : ESG Initiatives/Practices by Various Gene Editing Companies, 2023
• Table 9 : ESG Rankings for Companies in the Gene Editing Therapeutics Market, 2023
• Table 10 : Global DNA Sequencing Market, by Region, Through 2029
• Table 11 : DNA Transcription and Translation
• Table 12 : Types of Genetic Variation
• Table 13 : Molecular Diagnostic Technology Platforms
• Table 14 : Main Sequencing Applications
• Table 15 : Genetic Analysis Platform Comparison
• Table 16 : Key Applications in Microbial Sequencing
• Table 17 : Global DNA Sequencing Market, by Technology, Through 2029
• Table 18 : Different Generations of NGS Platforms
• Table 19 : Global DNA Sequencing Market, by Region, Through 2029
• Table 20 : Environmental Performance Initiatives in the DNA Sequencing Market
• Table 21 : Social Performance Initiatives in the DNA Sequencing Market
• Table 22 : Governance Performance Initiatives in the DNA Sequencing Market
• Table 23 : ESG Rankings for Key Players in DNA Sequencing Market, 2024*
• Table 24 : Global Market for Clinical Applications of Next-Generation Sequencing, by Disease Class, Through 2028
• Table 25 : Forces Influencing Growth in the Clinical NGS Market
• Table 26 : Key Trends in the Clinical NGS Testing Market
• Table 27 : Future Challenges in Implementing Clinical NGS
• Table 28 : Clinical NGS Research and Development Initiatives and Programs
• Table 29 : Global Market for Clinical NGS, by Disease Category, Through 2028
• Table 30 : Global Market for Clinical NGS, by Region, Through 2028
• Table 31 : Key Focus Areas in ESG Metrics
• Table 32 : ESG Rankings for Major Companies in the NGS Arena
• Table 33 : Illumina 2030 ESG Targets
• Table 34 : Global Market for RNA Sequencing, by Product, Through 2029
• Table 35 : Global Market for RNA Sequencing, by Technology, Through 2029
• Table 36 : Types of RNAs in Cells
• Table 37 : Comparison of Transcriptomics Methods
• Table 38 : Functional Elements in Sequencing Adapters
• Table 39 : Overview of Illumina's Sequencing Instruments
• Table 40 : Cloud Computing Providers for Genomics/RNA-Seq
• Table 41 : Global Market for RNA Sequencing, by Region, Through 2029
• Table 42 : Research Initiatives Focused on Personalized Medicine in Europe
• Table 43 : Key Focus Areas in ESG Metrics
• Table 44 : Environmental Performance Initiatives in the RNA Sequencing Market
• Table 45 : Social Performance Initiatives in the RNA Sequencing Market
• Table 46 : Governance Performance Initiatives in the RNA Sequencing Market
• Table 47 : ESG Rankings for Key Players in RNA Sequencing Market, 2024*
• Table 48 : Global Market for RNAi Technology, by Technology Type, Through 2029
• Table 49 : Cost Comparison of siRNA-approved Drugs and Alternative Therapies
• Table 50 : Global Market for RNAi Technology, by Technology Type, Through 2029
• Table 51 : RNAi Approved Drugs List
• Table 52 : miRNA-based Diagnostic Tools Available in Clinical Settings
• Table 53 : Global Market for RNAi Technology, by Region, Through 2029
• Table 54 : Key Focus Areas in ESG Metrices
• Table 55 : Environmental Initiatives, by Various RNAi Technology Companies
• Table 56 : ESG Rankings for Companies in the RNAi Technology Market, 2023
• Table 57 : Alnylam's ESG initiatives
• Table 58 : Global Market for Viral Vector and Plasmid DNA Technologies, by Product Type, Through 2028
• Table 59 : Global Incidence of All Cancers, by WHO Region, 2022-2050
• Table 60 : Global Market for Viral Vector and Plasmid DNA Technologies, Through 2028
• Table 61 : Global Market for Viral Vector and Plasmid DNA Technologies, by Product Type, Through 2028
• Table 62 : Global Market for Viral Vector and Plasmid DNA Technologies, by Application, Through 2028
• Table 63 : Global Market for Viral Vector and Plasmid DNA Technologies, by Region, Through 2028
• Table 64 : ESG Rankings of Major Companies, 2024*
• Table 65 : Lonza: ESG Performance
• Table 66 : Thermo Fisher: ESG Performance

List of Figures

• Figure 1 : Global Market for Gene Editing Therapeutics, 2021-2029
• Figure 2 : Emerging Technologies in the Genome-Editing Therapeutics Market
• Figure 3 : Global DNA Sequencing Market Shares, by Region, 2023
• Figure 4 : Global Market Shares of DNA Sequencing, by Technology, 2023
• Figure 5 : Global DNA Sequencing Market Shares, by Region, 2023
• Figure 6 : Global Market for Clinical Applications of Next-Generation Sequencing, by Disease Class, 2020-2028
• Figure 7 : Key Sustainable Practices Being Implemented in Research Laboratories
• Figure 8 : Global Market for RNA Sequencing, by Product, 2021-2029
• Figure 9 : Global Market for RNA Sequencing, by Technology, 2021-2029
• Figure 10 : RNA-Seq Experiments for Transcriptomics
• Figure 11 : RNA-Seq Experimental Workflow
• Figure 12 : Growth Strategy Recommendations: RNA Sequencing Market
• Figure 13 : Average Cost Per Genome: Y-o-Y Trend, 2011-2022
• Figure 14 : Global Market Shares of RNA Sequencing, by Product, 2024
• Figure 15 : Global Market Shares of RNA Sequencing, by Region, 2024
• Figure 16 : Growth Drivers in Asia-Pacific RNA Sequencing Market
• Figure 17 : Global Market for RNAi Technology, by Technology Type, 2021-2029
• Figure 18 : Global Market Shares of RNAi Technology, by Technology Type, 2023
• Figure 19 : Global Market for RNAi Technology, by Region, 2021-2029
• Figure 20 : Global Market Shares of RNAi Technology, by Region, 2023
• Figure 21 : Global Market for Viral Vector and Plasmid DNA Technologies, by Product Type, 2020-2028
• Figure 22 : Global Market Shares of Viral Vector and Plasmid DNA Technologies, by Product Type, 2022